Stage IIIB Breast Cancer Completed Phase 1 / 2 Trials for Vorinostat (DB02546)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00258349Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast CancerTreatment
NCT00368875Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast CancerTreatment